Change of Director's Interest Notice - Dr Ben Gil Price
Released
Released
Announcement PDF
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
ME_951958765_1
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity – Percheron Therapeutics Limited
ABN – 41 095 060 745
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director Ben Gil Price
Date of last notice 3 April 2025
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Not applicable
Date of change 22 December 2025
No. of securities held prior to change Fully paid ordinary shares
5,999,805
Unquoted options
3,000,000 exercisable at 8.3c per option on or
before 4 July 2029
Class Fully paid ordinary shares
Number acquired 2,000,000 fully paid ordinary shares
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
$17,220.06
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
ME_951958765_1
No. of securities held after change Fully paid ordinary shares
7,999,805
Unquoted options
3,000,000 exercisable at 8.3c per option on or
before 4 July 2029
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
Shares purchased on market.
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract Not applicable
Nature of interest Not applicable
Name of registered holder
(if issued securities)
Not applicable
Date of change Not applicable
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Not applicable
Interest acquired Not applicable
Interest disposed Not applicable
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
Not applicable
Interest after change Not applicable
Part 3 – +Closed period
Were the interests in the securities or contracts detailed
above traded during a +closed period where prior written
clearance was required?
No
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
ME_951958765_1
If so, was prior written clearance provided to allow the trade
to proceed during this period?
Not applicable
If prior written clearance was provided, on what date was this
provided?
Not applicable
Share your feedback
Discover